Gujarat Kidney and Super Speciality
add_icon

Gujarat Kidney and Super Speciality

110.40
-3.33
(-2.93%)
Market Cap
870.43 Cr
PE Ratio
67.07
Volume
3,58,692.00
Day High - Low
112.38 - 110.00
52W High-Low
123.00 - 98.36
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
870.43 Cr
EPS
1.85
PE Ratio
67.07
PB Ratio
3.23
Book Value
35.10
EBITDA
16.70
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
35.02
Debt to Equity
0.39
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
7,791.50
#1 1,12,029.82
60.27
#1 21,994.30
14.76
#1 1,505
36.08
73.44
1,083.60
1,05,409.29
74.88
7,184.10
#1 28.65
1,076
26.01
57.72
932.50
70,399.85
72.53
7,849.70
13.25
809
-22.38
58.15
1,787.00
36,519.28
48.08
5,575.00
12.29
790
-34.33
44.82
644.60
33,398.08
94.13
4,286.70
15.12
337
-8.85
63.37
1,130.00
30,373.31
59.67
3,771.40
12.59
481
-33.52
47.46
718.15
28,735.98
95.01
3,067.00
21.98
415
-43.89
60.54
448.20
14,184.19
89.04
1,757.00
27.64
110
#1 54.61
43.70
1,200.50
12,192.18
46.41
1,566.90
17.46
244
7.26
49.27
5,276.65
11,845.51
#1 24.53
599.90
11.69
58
12.46
45.80

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
634.55 %
Net Income Growth
458.82 %
Cash Flow Change
1,024.79 %
ROE
120.81 %
ROCE
177.89 %
EBITDA Margin (Avg.)
-14.69 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
12
10
15
13
23
Expenses
7
7
7
8
16
EBITDA
5
3
9
5
7
Operating Profit %
39 %
27 %
57 %
40 %
30 %
Depreciation
1
1
1
1
1
Interest
0
0
0
0
1
Profit Before Tax
4
2
8
4
5
Tax
1
0
2
1
1
Net Profit
3
1
5
3
4
EPS in ₹
0.52
0.22
0.85
0.47
0.52

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
4
4
21
55
Fixed Assets
3
0
14
31
Current Assets
1
1
7
22
Capital Work in Progress
0
0
0
0
Investments
0
0
0
0
Other Assets
1
4
7
24
Total Equity & Liabilities
4
4
21
55
Current Liabilities
4
4
4
22
Non Current Liabilities
0
0
6
7
Total Equity
0
0
11
27
Reserve & Surplus
0
0
2
15
Share Capital
0
0
0
11

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
0
1
2
Investing Activities
0
0
-18
Operating Activities
0
1
14
Financing Activities
0
-1
6

Share Holding

% Holding
Mar 2025
Dec 2025
Promoter
99.10 %
71.45 %
FIIs
0.00 %
10.47 %
DIIs
0.00 %
1.67 %
Government
0.00 %
0.00 %
Public / Retail
0.00 %
11.57 %
Others
0.90 %
4.84 %
No of Share Holders
7
7

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
14 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2026 108.65 110.40

Announcements

Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer6 hrs ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 15, 2026
Statement Of Deviation And Variation For Quarter Ended 31 Decembre 2025Feb 15, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 14, 2026
Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025Feb 14, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On February 14 2026 For The Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2025 And Other Businesses MFeb 14, 2026
Board Meeting Intimation for Postponement And Rescheduling Of Board MeetingFeb 11, 2026
Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025Feb 10, 2026
Board Meeting Outcome for Board Meeting Outcome For Board Meeting Hold On 5Th February 2026.Feb 05, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2026
Board Meeting Outcome for Outcome Of Board Meeting Hold On 6Th January 2026.Jan 06, 2026
Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held On 2Nd January 2026Jan 02, 2026
Closure of Trading WindowDec 30, 2025
Listing of Equity Shares of Gujarat Kidney and Super Speciality LtdDec 30, 2025

Technical Indicators

RSI(14)
Neutral
51.62
ATR(14)
Less Volatile
3.44
STOCH(9,6)
Neutral
54.27
STOCH RSI(14)
Oversold
15.35
MACD(12,26)
Bearish
-0.21
ADX(14)
Weak Trend
19.28
UO(9)
Bearish
41.54
ROC(12)
Downtrend And Accelerating
-3.29
WillR(14)
Neutral
-67.52